| Date Filed | Type | Description |
| 06/01/2023 |
4
| Kathiresan Sekar (Director) has filed a Form 4 on Relay Therapeutics, Inc.|
Txns:
| Granted 66,055 options to buy
@ $11.14, valued at
$735.9k
|
|
| 10/05/2022 |
4
| Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Sold 28,911 shares
@ $33.0157, valued at
$954.5k
Sold 11,185 shares
@ $34.1296, valued at
$381.7k
Sold 9,904 shares
@ $34.9723, valued at
$346.4k
Exercised 50,000 options to buy
@ $1.39, valued at
$69.5k
|
|
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Granted 332,000 options to buy
@ $30.94, valued at
$10.3M
|
|
| 01/06/2022 |
4
| Kathiresan Sekar (CEO) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Sold 1,870 shares
@ $39.9, valued at
$74.6k
Exercised 1,870 options to buy
@ $1.39, valued at
$2.6k
|
|
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |